Department of Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dong-an Rd, Shanghai, 200032, China.
Shanghai Medical College, Fudan University, Shanghai, 200032, China.
BMC Cancer. 2020 Jul 9;20(1):639. doi: 10.1186/s12885-020-07042-6.
Sentinel lymph node is the first stop of lymphatic spreading of cancer with known primary. The lymph node metastasis pattern of cancer of unknown primary (CUP) is unclear and has been presumed to follow the same pathway. To test this hypothesis, data of all 716 patients clinically diagnosed as CUP in our center were collected.
Diagnoses of lymph node metastasis were established by F-FDG PET-CT and/or biopsy pathology. Three hundred and forty-seven cases meeting the criteria were divided into three groups: pathology-confirmed primary with invasive biopsy or surgery of the suspicious lesion (group A, n = 64), primary still unknown even with invasive biopsy or surgery of the suspicious lesion (group B, n = 204), and others with no suspicious lesion or lesions who had not been sampled due to medical or other reasons (group C, n = 79). We assessed the clinicopathological features between these groups, and the relationship between lymph node metastasis pattern and confirmed primary site.
In group A, the primary sites of 61 cases were compatible with sentinel node theory, resulting in a positive predictive value of 95%. No significant differences in age, sex, bone metastasis, or visceral metastasis observed between group A and group B, except that group A had a higher ratio of differentiated carcinoma (94% vs. 77%, P = 0.003).
To our knowledge, this is the first evidence indicating that the majority of clinical CUP cases follow the sentinel node theory to spread in lymph nodes, which helps tracking the primary, especially for differentiated carcinoma.
前哨淋巴结是已知原发性癌症淋巴扩散的第一站。原发灶不明的癌症(CUP)的淋巴结转移模式尚不清楚,且被认为遵循相同的途径。为了验证这一假设,我们收集了中心所有 716 例临床诊断为 CUP 的患者的数据。
通过 F-FDG PET-CT 和/或活检病理确定淋巴结转移的诊断。符合标准的 347 例患者分为三组:经有创性活检或可疑病变手术证实有原发性的患者(A 组,n=64),即使进行了有创性活检或可疑病变手术仍未明确原发性的患者(B 组,n=204),以及因医疗或其他原因无可疑病变或未对病变进行取样的患者(C 组,n=79)。我们评估了这些组之间的临床病理特征,以及淋巴结转移模式与确诊原发性部位之间的关系。
在 A 组中,61 例患者的原发性部位符合前哨淋巴结理论,阳性预测值为 95%。A 组和 B 组在年龄、性别、骨转移或内脏转移方面无显著差异,除了 A 组分化型癌的比例更高(94%比 77%,P=0.003)。
据我们所知,这是第一个表明大多数临床 CUP 病例遵循前哨淋巴结理论在淋巴结中扩散的证据,这有助于追踪原发性部位,特别是分化型癌。